Related Experiment Video

Updated: Mar 3, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future

Christi M Steendam1,2, Floris Dammeijer1, Joachim G J V Aerts1,2

  • 1Department of Pulmonary Medicine, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.

Immunotherapy
|May 6, 2017
PubMed

Insights

Immunotherapies offer new hope for non-small cell lung cancer (NSCLC), a leading cause of cancer death. This review covers current immune checkpoint inhibitors, vaccines, cellular therapies, and future combination strategies for NSCLC treatment.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Non-small cell lung cancer (NSCLC) remains a primary global cause of cancer mortality.
  • Prognosis for NSCLC patients is generally poor, necessitating advancements in treatment.
  • The landscape of cancer treatment is evolving with the rise of immunotherapies.

Purpose of the Study:

  • To review the current status of immunotherapeutic strategies in NSCLC.
  • To discuss the future perspectives of immunotherapy in NSCLC management.
  • To explore promising rational combination strategies for NSCLC.

Main Methods:

  • Literature review of current immunotherapeutic approaches for NSCLC.
  • Analysis of immune checkpoint inhibitors, cancer vaccines, and cellular therapies.
  • Discussion of evidence and rationale for combination therapies.

Main Results:

  • Immune checkpoint inhibitors are a key component of current NSCLC immunotherapy.
  • Cancer vaccines and cellular therapies are emerging modalities with potential in NSCLC.
  • Rational combinations of therapies show promise for improved clinical outcomes.

Conclusions:

  • Immunotherapy has significantly impacted NSCLC treatment paradigms.
  • Continued research into novel agents and combination strategies is crucial.
  • Clinicians must stay informed about evolving immunotherapeutic options for NSCLC.
Keywords:
cancer vaccinescellular therapycombination therapyimmune checkpoint inhibitorsimmunotherapynon-small-cell lung cancer

More Related Videos

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.4K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K